Growth Metrics

ClearPoint Neuro (CLPT) Gross Profit Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.52%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.76%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.41%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.59%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.74%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.30%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 27.39%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.74%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.72%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn 51.13%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 51.13%
Dec 31, 2025 34.48%
Sep 30, 2025 15.54%
Jun 30, 2025 11.39%
Mar 31, 2025 13.41%
Dec 31, 2024 18.66%
Sep 30, 2024 48.09%
Jun 30, 2024 59.56%
Mar 31, 2024 41.32%
Dec 31, 2023 19.22%
Sep 30, 2023 -11.04%
Jun 30, 2023 -3.96%
Mar 31, 2023 -0.90%
Dec 31, 2022 5.72%
Sep 30, 2022 20.98%
Jun 30, 2022 43.14%
Mar 31, 2022 23.60%
Dec 31, 2021 20.47%
Sep 30, 2021 16.25%
Jun 30, 2021 35.68%
Mar 31, 2021 19.69%
Dec 31, 2020 130.92%
Sep 30, 2020 40.32%
Jun 30, 2020 6.34%
Mar 31, 2020 37.70%
Dec 31, 2019 -1,850.09%
Sep 30, 2019 48.69%
Jun 30, 2019 118.87%
Mar 31, 2019 139.89%
Sep 30, 2016 33.76%
Jun 30, 2016 249.24%
Mar 31, 2016 13.25%
Sep 30, 2015 138.15%
Jun 30, 2015 -163.29%
Mar 31, 2015 25.31%
Dec 31, 2014 79.84%
Sep 30, 2014 180.83%
Jun 30, 2014 186.53%
Mar 31, 2014 751.86%
Dec 31, 2013 -171.55%
Sep 30, 2013 -133.76%
Jun 30, 2013 1,504.56%
Mar 31, 2013 -1,186.70%
Dec 31, 2012 1,976.11%
Sep 30, 2012 17.90%
Jun 30, 2012 -133.78%
Mar 31, 2012 -99.04%